Pfizer Unit's Antibiotic Patent Faces Fed. Circ. Challenge
Apotex Inc. called on a Federal Circuit panel Tuesday to make the Patent Trial and Appeal Board take another look at a Pfizer Inc. unit's patent on a antibiotic formula, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article